Literature DB >> 3140742

Enhanced expression of ras gene products in psoriatic epidermis.

H Kobayashi1, H Yasuda, A Ohkawara, H Dosaka, A Oda, Y Ogiso, N Kuzumaki.   

Abstract

The ras oncogene product ras p21 is structurally homologous to guanine nucleotide-binding proteins and plays an important role in transducing signals elicited by membrane receptors into intracellular metabolism. We examined psoriatic tissues for expression of ras p21 and compared them with normal skin, using the indirect immunofluorescence technique with the anti-ras p21 monoclonal antibody (MoAb), rp-35. In normal epidermis of five healthy individuals and uninvolved epidermis of three psoriatic patients, only the basal layer was positively stained by rp-35. The spinous layer was negative or faintly positive. In contrast, all psoriatic epidermis obtained from 13 psoriatic patients had strong reactivity with rp-35 throughout the epidermis. There were no differences in the staining pattern of hair follicles, sebaceous glands, eccrine glands, and eccrine ducts, which positively reacted with rp-35, between psoriatic and normal skin. The functions of ras p21 have not been clearly identified in mammalian cells; however recent reports reveal that cyclic AMP production is inhibited by the transfection of activated ras gene into normal cells. Enhanced expression of ras p21 in psoriatic epidermis may be indicative of some mechanism of defective beta-adrenergic responsiveness, which is considered to be one of the important pathophysiological phenomena causing the hyperproliferative condition in psoriasis.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3140742     DOI: 10.1007/bf00440597

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  32 in total

1.  Expression of the 21,000 molecular weight ras protein in a spectrum of benign and malignant human mammary tissues.

Authors:  N Ohuchi; A Thor; D L Page; P H Hand; S A Halter; J Schlom
Journal:  Cancer Res       Date:  1986-05       Impact factor: 12.701

Review 2.  Psoriasis as a possible defect of the adenyl cyclase-cyclic AMP cascade. A defective chalone mechanism?

Authors:  J J Voorhees; E A Duell
Journal:  Arch Dermatol       Date:  1971-10

Review 3.  Cellular oncogenes and multistep carcinogenesis.

Authors:  H Land; L F Parada; R A Weinberg
Journal:  Science       Date:  1983-11-18       Impact factor: 47.728

4.  On the lack of response to catecholamine stimulation by the adenyl cyclase system in psoriatic lesions.

Authors:  K Yoshikawa; K Adachi; K M Halprin; V Levine
Journal:  Br J Dermatol       Date:  1975-06       Impact factor: 9.302

5.  Expression of ras oncogene p21 antigen in normal and proliferative thyroid tissues.

Authors:  T L Johnson; R V Lloyd; A Thor
Journal:  Am J Pathol       Date:  1987-04       Impact factor: 4.307

6.  Isolation of two proteins with high affinity for guanine nucleotides from membranes of bovine brain.

Authors:  P C Sternweis; J D Robishaw
Journal:  J Biol Chem       Date:  1984-11-25       Impact factor: 5.157

7.  Monoclonal antibodies to the p21 products of the transforming gene of Harvey murine sarcoma virus and of the cellular ras gene family.

Authors:  M E Furth; L J Davis; B Fleurdelys; E M Scolnick
Journal:  J Virol       Date:  1982-07       Impact factor: 5.103

8.  Epinephrine-induced cyclic AMP accumulation in the psoriatic epidermis.

Authors:  H Iizuka; K Umeda; H Koizumi; T Aoyagi; Y Miura
Journal:  Acta Derm Venereol       Date:  1981       Impact factor: 4.437

9.  ras Oncogene p21 expression is increased in premalignant lesions and high grade bladder carcinoma.

Authors:  M V Viola; F Fromowitz; S Oravez; S Deb; J Schlom
Journal:  J Exp Med       Date:  1985-05-01       Impact factor: 14.307

10.  Immunocytochemical demonstration of p21 ras family oncogene product in normal mucosa and in premalignant and malignant tumours of the colorectum.

Authors:  I B Kerr; F D Lee; M Quintanilla; A Balmain
Journal:  Br J Cancer       Date:  1985-11       Impact factor: 7.640

View more
  3 in total

1.  Growth advantage by overexpression of normal Harvey ras proto-oncogene in cultured rat epidermal keratinocytes.

Authors:  K Yamanishi; F M Liew; Y Hosokawa; S Kishimoto; H Yasuno
Journal:  Arch Dermatol Res       Date:  1990       Impact factor: 3.017

2.  No evidence for the mutation of ras gene in psoriatic epidermis.

Authors:  H Takahashi; H Iizuka; M Katagiri
Journal:  Arch Dermatol Res       Date:  1990       Impact factor: 3.017

3.  Vitamin D3 inhibits proliferation and increases c-myc expression in fibroblasts from psoriatic patients.

Authors:  M Casado; M Martin; A Muñoz; J Bernal
Journal:  J Endocrinol Invest       Date:  1998-09       Impact factor: 4.256

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.